FDA approves new use of synthetic vitamin B9 — but not for autism symptoms
Cristiana Gigina
The Food and Drug Administration on Tuesday announced a new approved use for the drug leucovorin, a synthetic form of vitamin B9 that the Trump administration has touted as a treatment for autism symptoms . But the new approval is not for autism — it’s for cerebral folate deficiency, a rare neurological condition characterized by low levels of vitamin B9 in the brain. Contrary to the messages President Donald Trump and FDA Commissioner Marty Makary gave in September when they announced a plan
astăzi